Previous studies have shown that AKT3 plays an important role in cell proliferation, migration, and survival [50–53] and have revealed that it is also involved in the regulation of estrogen receptor-binding fragment-associated antigen 9 (EBAG9) and vascular endothelial growth factor (VEGF) secretion in ovarian cancer cells [54]. Here, AKT3 is linked to ovarian carcinoma.